Acousia Therapeutics GmbH

Develops small molecule drug candidates with a dual mode of action for acute and chronic forms of hearing loss. It focuses on sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear. Source

Keywords: small molecule hearing loss sensorineural hearing loss outer hair cells